Early research (Phase 1)Study completedNCT01069575
What this trial is testing
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer
Who this might be right for
Non-Small Cell Lung Cancer
Shiga University 18